Motor function without medication (measured by the Unified Parkinson’s Disease Rating Scale) improved from a mean of 42.8 to 21.1 at year 1 (51%) and 27.6 at year 5 (36%). HealthDay News — Subthalamic ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, No. 19 (May 10, 2022), pp. 1-10 (10 pages) Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is ...
(A) Experimental design. (B) Behavior assessments using open field tests. Heatmaps illustrate time spent (red) and movement trajectories (green). The PD group exhibited decreased movement speed ...
# Investigating the impact of motor symptom asymmetry on clinical outcomes ...
Deep brain stimulation—implants in the brain that act as a kind of "pacemaker"—has led to clinical improvements in half of the participants with treatment-resistant severe depression in an open-label ...
THURSDAY, Oct. 16, 2025 (HealthDay News) -- Subthalamic deep brain stimulation (DBS) is an effective long-term therapy for Parkinson disease (PD), according to a study published online Sept. 15 in ...